Keybank National Association Veracyte, Inc. Transaction History

Keybank National Association

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $134,526 - $231,236	-4,084 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$44.47 - $81.38 $8,093 - $14,811	-182 Reduced 4.27%	4,084 $220,000
Q4 2020 Feb 09, 2021	BUY	$32.49 - $61.88 $138,602 - $263,980	4,266 New	4,266 $209,000

311

82M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.